These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 21529949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The immunostimulatory activity of phosphorothioate CpG oligonucleotides is affected by distal sequence changes.
    Roberts TL, Dunn JA, Sweet MJ, Hume DA, Stacey KJ.
    Mol Immunol; 2011 Apr; 48(8):1027-34. PubMed ID: 21324527
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK, Rasmussen WL, Krieg AM.
    J Immunol; 1996 Sep 01; 157(5):1840-5. PubMed ID: 8757300
    [Abstract] [Full Text] [Related]

  • 7. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM.
    Immunology; 2004 Oct 01; 113(2):212-23. PubMed ID: 15379982
    [Abstract] [Full Text] [Related]

  • 8. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW, Jung J, Lee Y, Kim TY, Choi SY, Park J, Kim DS, Kwon HJ.
    Mol Immunol; 2006 May 01; 43(13):2107-18. PubMed ID: 16442622
    [Abstract] [Full Text] [Related]

  • 9. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep 01; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 10. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan 01; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 11. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
    Tewary P, Sukumaran B, Saxena S, Madhubala R.
    Vaccine; 2004 Aug 13; 22(23-24):3053-60. PubMed ID: 15297055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC.
    J Immunol; 1998 Sep 15; 161(6):3042-9. PubMed ID: 9743369
    [Abstract] [Full Text] [Related]

  • 15. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z, Guo K, Schluesener HJ.
    J Neuroimmunol; 2005 Apr 15; 161(1-2):68-77. PubMed ID: 15748945
    [Abstract] [Full Text] [Related]

  • 16. CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-kappaB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells.
    Lee KW, Kim DS, Kwon HJ.
    Mol Immunol; 2004 Aug 15; 41(10):955-64. PubMed ID: 15302158
    [Abstract] [Full Text] [Related]

  • 17. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 15; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 18. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles.
    Mui B, Raney SG, Semple SC, Hope MJ.
    J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1185-92. PubMed ID: 11504819
    [Abstract] [Full Text] [Related]

  • 19. CpG motifs in bacterial DNA trigger direct B-cell activation.
    Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM.
    Nature; 1995 Apr 06; 374(6522):546-9. PubMed ID: 7700380
    [Abstract] [Full Text] [Related]

  • 20. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
    Hofmann C, Dunger N, Grunwald N, Hämmerling GJ, Hoffmann P, Schölmerich J, Falk W, Obermeier F.
    Gut; 2010 Oct 06; 59(10):1347-54. PubMed ID: 20732920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.